Skip to main content
Book cover

Biotechnology and Production of Anti-Cancer Compounds

  • Book
  • © 2017

Overview

  • Discusses the recent developments and techniques about anti-cancer drugs from plants, in vitro protocols to optimize the production and their mode of action and biosynthetic pathways
  • Future strategies and goals to find out the ways to obtain the highly demanded anticancer compounds in an eco-friendly, economic and efficient ways
  • Valuable content for any professional or student in the area of plant natural products, phytochemistry, pharmaceutical sciences, medicines, and drug discovery
  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

Keywords

About this book

This book discusses cancers and the resurgence of public interest in plant-based and herbal drugs. It also describes ways of obtaining anti-cancer drugs from plants and improving their production using biotechnological techniques. It presents methods such as cell culture, shoot and root culture, hairy root culture, purification of plant raw materials, genetic engineering, optimization of culture conditions as well as metabolic engineering with examples of successes like taxol, shikonin, ingenol mebutate and podophylotoxin. In addition, it describes the applications and limitations of large-scale production of anti-cancer compounds using biotechnological means. Lastly, it discusses future economical and eco-friendly strategies for obtaining anti-cancer compounds using biotechnology. 

Editors and Affiliations

  • Graduate Program in Health Sciences Biological and Health Sciences Center, Federal University of Maranhao, Sao Luis, MA, Brazil

    Sonia Malik

About the editor

Dr. Malik has obtained her doctoral degree in Plant Biotechnology from CSIR- Institute of Himalayan Bioresource Technology, Palampur, India in July 2009. She did Masters (Gold Medalist) in Honours Botany with specialization in Plant Biotechnology and Tissue Culture in 2001 from Guru Nanak Dev University, Amritsar, India. Her basic area of research is plant secondary metabolites and genetic manipulation and she did work on several medicinal plants. After her post-doctoral studies at Brazil, Czech Republic and United Kingdom, Dr. Malik has joined as a Professor in Biology at Biological and Health Sciences Center, Federal University of Maranhão, Sao Luis since February 2015. At present she is an active member of Post-graduate research program at UFMA and actively involved in research, teaching and supervising research students at UG/PG levels. She has been awarded as FAPEMA Junior Researcher grant in August 2015. To date, Dr. Malik has published more than 20 research articles inreputed journals, 2 book chapters and several abstracts in National and International conferences/symposia. She is editorial board member and reviewer of many International Scientific Journals.

Bibliographic Information

Publish with us